What is Scienture Holdings, Inc.'s market cap?

Scienture Holdings, Inc. (SCNX) has a market capitalization of $13.5M and trades on XNAS.

Who are Scienture Holdings, Inc.'s competitors?

Scienture Holdings, Inc.'s key competitors include Emergent BioSolutions Inc., Pacira BioSciences, Inc., Biohaven Ltd., and others. These companies compete in similar markets and product categories.

Who does Scienture Holdings, Inc. partner with?

Scienture Holdings, Inc.'s notable partners include Kindeva Drug Delivery L.P., Anthem Biosciences Pvt, Ltd., Innocore Technologies, B.V., and others.

What subsidiaries does Scienture Holdings, Inc. have?

Scienture Holdings, Inc.'s subsidiaries include Scienture LLC.

Where is Scienture Holdings, Inc. headquartered?

Scienture Holdings, Inc. is headquartered in United States of America and employs approximately 8 people. It has been publicly traded since 2008.

Scienture Holdings, Inc.

SCNX

Scienture Holdings, Inc. is a specialty pharmaceutical company focused on the development and commercialization of medicines for cardiovascular and central nervous system diseases.

Market cap

$13.47M-29.2%

Table of contents

Earnings

Q1 2026 report

May 11, 2026

Revenue$56.3MBeat by $55.9M EPS-$0.08Beat by $0.15

Read the full report

Next report

Aug 17, 2026 (in a month)

Revenue estimate$2.0M

EPS estimate-$0.09

Competitors

By market cap

AbbVie$446.54B+33.6%

Neurocrine Biosciences$17.9B+40.3%

Biohaven$2.5B+67.7%

Pacira BioSciences, Inc.$1.0B-6.6%

Emergent Biosolutions$420.0M+10.7%

Vanda Pharmaceuticals$395.7M+35.1%

Scilex Holding Company$64.2M+83.8%

SCN

Scienture Holdings, Inc.$13.5M-29.2%

By revenue growth

Neurocrine Biosciences+28.6%

AbbVie+9.5%

Pacira BioSciences, Inc.+4.6%

Emergent Biosolutions-29.9%

Scilex Holding Company-33.2%

By net margin

Neurocrine Biosciences21.55%+8.9pp

Emergent Biosolutions9.62%+36.6pp

AbbVie5.79%-1.5pp

Pacira BioSciences, Inc.0.699%+16.5pp

Scilex Holding Company-1,162.43%-1,015pp

Profile

Scienture Holdings, Inc. is a specialty pharmaceutical company focused on the development and commercialization of medicines for cardiovascular and central nervous system diseases. The company utilizes the 505(b)(2) regulatory pathway to create improved formulations of existing drugs, such as oral liquids and novel delivery systems, to enhance patient convenience and clinical outcomes. Its core value proposition lies in addressing unmet needs in markets like hypertension, opioid overdose, and migraine management.

Competitive position

Scienture positions itself as an innovator in drug delivery, offering the first FDA-approved liquid formulation of losartan and the highest-dose naloxone nasal spray currently available.

GeographiesUnited States

Customer segmentsHealthcare providers, Wholesalers, Pharmacies

Business modelProduct development, Licensing, B2B, Research and Development

SuppliersContract Manufacturing Organizations (CMOs), Raw material suppliers, Contract Research Organizations (CROs), Intellectual property licensors

CustomersPharmaceutical wholesalers, Specialty pharmacies, Hospitals, Federal and state health entities

CountryUnited States of America

Listed2008

Employees8.0

CEOShankar Hariharan

SectorPHARMACEUTICAL PREPARATIONS

IndustryPHARMACEUTICAL PREPARATIONS

Websitescienture.com

FilingsSEC EDGAR

Questions, answered.

What is Scienture Holdings, Inc.'s market cap?: Scienture Holdings, Inc. (SCNX) has a market capitalization of $13.5M and trades on XNAS.
Who are Scienture Holdings, Inc.'s competitors?: Scienture Holdings, Inc.'s key competitors include Emergent BioSolutions Inc., Pacira BioSciences, Inc., Biohaven Ltd., and others. These companies compete in similar markets and product categories.
Who does Scienture Holdings, Inc. partner with?: Scienture Holdings, Inc.'s notable partners include Kindeva Drug Delivery L.P., Anthem Biosciences Pvt, Ltd., Innocore Technologies, B.V., and others.
What subsidiaries does Scienture Holdings, Inc. have?: Scienture Holdings, Inc.'s subsidiaries include Scienture LLC.
Where is Scienture Holdings, Inc. headquartered?: Scienture Holdings, Inc. is headquartered in United States of America and employs approximately 8 people. It has been publicly traded since 2008.